Bioperfectus Launches New Product-Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit to Combat COVID-19 Globally
Bioperfectus Novel Corona Virus (SARS-CoV-2) IgM/IgG Rapid Test obtained EU CE certification
HIV (human immunodeficiency virus) is a virus that attacks cells that help the body fight infection, making a person more vulnerable to other infections and diseases.
Influenza and COVID-19 are different diseases caused by completely different viruses. COVID-19 is about 4-5 times as contagious as the flu. It is very important for us to distinguish between these two since it is the first step to determine a therapy solution to the diseases.
It is still a challenging thing for the northern hemisphere encountering "twindemic", a simultaneous COVID-19 and flu outbreak.
Bioperfectus Influenza Real-Time PCR reagent Kit is used to determine the presence of Influenza A or B in a patient's specimen.
Something you have to know about Respiratory Tract Infection...
On June 18th, US Food & Drug Administration granted China’s Jiangsu Bioperfectus Technologies an Emergency Use Authorization for its COVID-19 Coronavirus Real-Time PCR Kit.
09 July 2020，Jiangsu Bioperfectus Technologies Co.,Ltd COVID-19 Coronavirus Real Time PCR Kit (product code JC10223-1NW-50T) was listed on World Health Organization Emergency Use Listing for In vitro diagnostics (IVDs) detecting SARS-CoV-2.
Bioperfectus Assisting Myanmar Government in Fighting Against the Pandemic
